Crinetics Pharmaceuticals Inc (CRNX)
43.44
+0.47
(+1.09%)
USD |
NASDAQ |
Apr 22, 16:00
43.46
+0.02
(+0.05%)
After-Hours: 20:00
Crinetics Pharmaceuticals Price to Book Value: 6.279 for April 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 22, 2024 | 6.279 |
| April 19, 2024 | 6.212 |
| April 18, 2024 | 6.217 |
| April 17, 2024 | 6.362 |
| April 16, 2024 | 6.287 |
| April 15, 2024 | 6.314 |
| April 12, 2024 | 6.446 |
| April 11, 2024 | 6.943 |
| April 10, 2024 | 6.635 |
| April 09, 2024 | 6.781 |
| April 08, 2024 | 6.713 |
| April 05, 2024 | 6.871 |
| April 04, 2024 | 6.743 |
| April 03, 2024 | 6.884 |
| April 02, 2024 | 6.649 |
| April 01, 2024 | 6.726 |
| March 28, 2024 | 6.766 |
| March 27, 2024 | 6.422 |
| March 26, 2024 | 6.269 |
| March 25, 2024 | 6.233 |
| March 22, 2024 | 6.402 |
| March 21, 2024 | 6.501 |
| March 20, 2024 | 6.576 |
| March 19, 2024 | 6.531 |
| March 18, 2024 | 5.483 |
| Date | Value |
|---|---|
| March 15, 2024 | 5.628 |
| March 14, 2024 | 5.523 |
| March 13, 2024 | 5.854 |
| March 12, 2024 | 5.890 |
| March 11, 2024 | 6.009 |
| March 08, 2024 | 6.113 |
| March 07, 2024 | 6.144 |
| March 06, 2024 | 6.291 |
| March 05, 2024 | 6.206 |
| March 04, 2024 | 6.290 |
| March 01, 2024 | 6.654 |
| February 29, 2024 | 5.285 |
| February 28, 2024 | 5.520 |
| February 27, 2024 | 5.224 |
| February 26, 2024 | 4.992 |
| February 23, 2024 | 4.757 |
| February 22, 2024 | 4.740 |
| February 21, 2024 | 4.699 |
| February 20, 2024 | 4.831 |
| February 16, 2024 | 4.783 |
| February 15, 2024 | 4.669 |
| February 14, 2024 | 4.592 |
| February 13, 2024 | 4.551 |
| February 12, 2024 | 4.970 |
| February 09, 2024 | 4.990 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.124
Minimum
Oct 30 2020
7.739
Maximum
Sep 29 2023
3.764
Average
3.534
Median
Apr 01 2021
Price to Book Value Benchmarks
| Catalyst Pharmaceuticals Inc | 4.591 |
| Geron Corp | 8.215 |
| Madrigal Pharmaceuticals Inc | 10.49 |
| PTC Therapeutics Inc | -- |
| Syndax Pharmaceuticals Inc | 3.217 |
Price to Book Value Related Metrics
| PS Ratio | 534.18 |
| PEG Ratio | -0.5594 |
| Price | 43.44 |
| Earnings Yield | -8.52% |
| Market Cap | 3.385B |
| PEGY Ratio | -0.5594 |